Lv5
850 积分 2023-10-11 加入
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
10小时前
待确认
Outcomes of Children and Young Adults with Acute Lymphoblastic Leukaemia Administered Inotuzumab Pre CAR-T Therapy
2天前
已完结
Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
3天前
求助中
Leukapheresis for CAR-T cell production and therapy
3天前
已完结
Recognizing, defining, and managing CAR-T hematologic toxicities
7天前
已完结
Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cells
7天前
已完结
Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL
7天前
已关闭
Timeline and outcomes of viral and fungal infections after Chimeric Antigen Receptor (CAR) T-cell therapy: A large database analysis
7天前
已关闭
Breast cancer epigenetics: current and evolving treatment
7天前
已完结
[Consensus on the molecular residual disease testing in solid tumor]
8天前
已完结
皖公网安备34019202002308
